Skip to content

ReSure Sealant Pivotal Study

ReSure Sealant Pivotal Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01498224
Enrollment
488
Registered
2011-12-23
Start date
2011-12-31
Completion date
2012-11-30
Last updated
2016-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Surgery Incision Leak

Keywords

Cataract surgery

Brief summary

This is a randomized multicenter study to evaluate the safety and effectiveness of ReSure Sealant compared to sutures for preventing incision leakage within the first 7 days of cataract surgery.

Interventions

Comparison of ReSure Sealant to suture(s)

PROCEDURESutures

Sponsors

Ocular Therapeutix, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject has a cataract and is expected to undergo clear cornea cataract surgery with phacoemulsification and implantation of posterior chamber intraocular lens * Subject must be 22 years of age or older

Exclusion criteria

* Any intraocular inflammation in study eye or presence of ocular pain in operative eye at preoperative assessment * Previous corneal or retinal surgery or planned multiple procedures during cataract surgery.

Design outcomes

Primary

MeasureTime frame
Proportion of eyes with any clear corneal incision/suture leakage as determined by positive Seidel test indicating fluid egress within first 7 days after surgery.Days 1-28

Secondary

MeasureTime frameDescription
Foreign Body SensationDays 1-28
Best corrected visual acuityDay 1Best corrected visual acuity worse than 20/40 at day 1

Other

MeasureTime frameDescription
Corneal edema at 1 dayDay 1Corneal edema at 1 day (moderate to severe stromal edema)
Presence of ReSure Sealant or suture(s)Day 28Presence of ReSure Sealant or suture(s)at every follow-up visit
Anterior chamber inflammationDay 1Anterior chamber inflammation (defined as greater than or equal to grade 2+ anterior chamber cells) at day 1
Presence of blue colorant in ReSure SealantDay 28Presence of blue colorant in ReSure Sealant at every follow-up visit
Device ease of useDay 0Device ease of use during application

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026